TY - JOUR
T1 - Health effects of dietary risks in 195 countries, 1990–2017
T2 - a systematic analysis for the Global Burden of Disease Study 2017
AU - GBD 2017 Diet Collaborators
AU - Afshin, Ashkan
AU - Sur, Patrick John
AU - Fay, Kairsten A.
AU - Cornaby, Leslie
AU - Ferrara, Giannina
AU - Salama, Joseph S.
AU - Mullany, Erin C.
AU - Abate, Kalkidan Hassen
AU - Abbafati, Cristiana
AU - Abebe, Zegeye
AU - Afarideh, Mohsen
AU - Aggarwal, Anju
AU - Agrawal, Sutapa
AU - Akinyemiju, Tomi
AU - Alahdab, Fares
AU - Bacha, Umar
AU - Bachman, Victoria F.
AU - Badali, Hamid
AU - Badawi, Alaa
AU - Bensenor, Isabela M.
AU - Bernabe, Eduardo
AU - Biadgilign, Sibhatu Kassa K.
AU - Biryukov, Stan H.
AU - Cahill, Leah E.
AU - Carrero, Juan J.
AU - Cercy, Kelly M.
AU - Dandona, Lalit
AU - Dandona, Rakhi
AU - Dang, Anh Kim
AU - Degefa, Meaza Girma
AU - El Sayed Zaki, Maysaa
AU - Esteghamati, Alireza
AU - Esteghamati, Sadaf
AU - Fanzo, Jessica
AU - Farinha, Carla Sofia e.Sá
AU - Farvid, Maryam S.
AU - Farzadfar, Farshad
AU - Feigin, Valery L.
AU - Fernandes, João C.
AU - Flor, Luisa Sorio
AU - Foigt, Nataliya A.
AU - Forouzanfar, Mohammad H.
AU - Ganji, Morsaleh
AU - Geleijnse, Johanna M.
AU - Gillum, Richard F.
AU - Goulart, Alessandra C.
AU - Grosso, Giuseppe
AU - Guessous, Idris
AU - Hamidi, Samer
AU - Hankey, Graeme J.
N1 - Funding Information:
JMG reports grants from Unilever. LJ reports personal fees from Mills Scientific Council. SL reports personal fees from Amgen, Berlin-Chemie, Merck Sharp & Dohme (MSD), Novo Nordisk, Sanofi-Aventis, Synlab, Unilever, and Upfield, and non-financial support from Preventicus. SL is also a member of the Scientific Board of the German Nutrition Society and a coauthor of the evidence-based guideline Fat Intake and Prevention of Nutrition-Related Diseases of the German Nutrition Society. WMä reports grants and personal fees from Siemens Diagnostics, Aegerion Pharmaceuticals, Amgen, AstraZeneca, Danone Research, Pfizer, BASF, Numares AG, and Berlin-Chemie; personal fees from Hoffmann LaRoche, MSD, Sanofi, and Synageva; grants from Abbott Diagnostics; and employment with Synlab Holding Deutschland GmbH. WMe is currently a program analyst for Population and Development at the Peru Country Office of the United Nations Population Fund-UNFPA, an institution that does not necessarily endorse this study. RMi reports grants from the US National Institutes of Health, Bill & Melinda Gates Foundation, and Unilever; and personal fees from World Bank and Bunge. DM reports research funding from the US National Institutes of Health and the, Bill & Melinda Gates Foundation; personal fees from GOED, DSM, Nutrition Impact, Pollock Communications, Bunge, Indigo Agriculture, Amarin, Acasti Pharma, and America's Test Kitchen; scientific advisory board roles with Elysium Health (with stock options), Omada Health, and DayTwo; and chapter royalties from UpToDate. In addition, DM is listed as a co-inventor on patents US8889739 and US9987243 issued to Tufts University (Somerville, MA, USA; unlicensed) for use of trans-palmitoleic acid to prevent and treat insulin resistance, type 2 diabetes, and related conditions, as well as reduce metabolic risk factors. CDR reports personal fees from Dairy Management Institute. AES reports personal fees from IEM, Novartis, Servier, and Abbott. AGT reports grants from National Health and Medical Research Council, Australia. All other authors declare no competing interests.
Funding Information:
The work of HB was financially supported by Mazandaran University of Medical Sciences, Sari, Iran. AB is supported by the Public Health Agency of Canada. JCF acknowledges funding support from Fundação para a Ciência e a Tecnologia, through project UID/Multi/50016/2013. TL is supported by the Academy of Finland ( grants number 287488 and number 319200 ). The work of SL is funded by the German Federal Ministry of Education and Research (nutriCARD; grant agreement number 01EA1411A ). TM acknowledges additional institutional support from the Competence Cluster for Nutrition and Cardiovascular Health (nutriCARD), in Jena, Halle, and Leipzig, Germany. AES is supported by the South African Medical Research Council and the South African Research Chair Initiative by the National Research Foundation. AGT acknowledges fellowship funding from the National Health and Medical Research Council (Australia). ST's work was supported by the Foundation for Education and European Culture (IPEP), the Sara Borrell postdoctoral program (reference number CD15/00019 from the Instituto de Salud Carlos III, Spain) and the Fondos Europeo de Desarrollo Regional (FEDER). TW acknowledges academic support from the Department of Medicine, Faculty of Medicine, University of Rajarata, Sri Lanka; the World Federation of Neurology; and the World Federation for Neuro-Rehabilitation. JHW was supported by a Scientia Fellowship from the University of New South Wales (Australia). We thank Pauline Kim and Adrienne Chew for editing assistance.
Publisher Copyright:
© 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/5/11
Y1 - 2019/5/11
N2 - Background: Suboptimal diet is an important preventable risk factor for non-communicable diseases (NCDs); however, its impact on the burden of NCDs has not been systematically evaluated. This study aimed to evaluate the consumption of major foods and nutrients across 195 countries and to quantify the impact of their suboptimal intake on NCD mortality and morbidity. Methods: By use of a comparative risk assessment approach, we estimated the proportion of disease-specific burden attributable to each dietary risk factor (also referred to as population attributable fraction)among adults aged 25 years or older. The main inputs to this analysis included the intake of each dietary factor, the effect size of the dietary factor on disease endpoint, and the level of intake associated with the lowest risk of mortality. Then, by use of disease-specific population attributable fractions, mortality, and disability-adjusted life-years (DALYs), we calculated the number of deaths and DALYs attributable to diet for each disease outcome. Findings: In 2017, 11 million (95% uncertainty interval [UI]10–12)deaths and 255 million (234–274)DALYs were attributable to dietary risk factors. High intake of sodium (3 million [1–5]deaths and 70 million [34–118]DALYs), low intake of whole grains (3 million [2–4]deaths and 82 million [59–109]DALYs), and low intake of fruits (2 million [1–4]deaths and 65 million [41–92]DALYs)were the leading dietary risk factors for deaths and DALYs globally and in many countries. Dietary data were from mixed sources and were not available for all countries, increasing the statistical uncertainty of our estimates. Interpretation: This study provides a comprehensive picture of the potential impact of suboptimal diet on NCD mortality and morbidity, highlighting the need for improving diet across nations. Our findings will inform implementation of evidence-based dietary interventions and provide a platform for evaluation of their impact on human health annually. Funding: Bill & Melinda Gates Foundation.
AB - Background: Suboptimal diet is an important preventable risk factor for non-communicable diseases (NCDs); however, its impact on the burden of NCDs has not been systematically evaluated. This study aimed to evaluate the consumption of major foods and nutrients across 195 countries and to quantify the impact of their suboptimal intake on NCD mortality and morbidity. Methods: By use of a comparative risk assessment approach, we estimated the proportion of disease-specific burden attributable to each dietary risk factor (also referred to as population attributable fraction)among adults aged 25 years or older. The main inputs to this analysis included the intake of each dietary factor, the effect size of the dietary factor on disease endpoint, and the level of intake associated with the lowest risk of mortality. Then, by use of disease-specific population attributable fractions, mortality, and disability-adjusted life-years (DALYs), we calculated the number of deaths and DALYs attributable to diet for each disease outcome. Findings: In 2017, 11 million (95% uncertainty interval [UI]10–12)deaths and 255 million (234–274)DALYs were attributable to dietary risk factors. High intake of sodium (3 million [1–5]deaths and 70 million [34–118]DALYs), low intake of whole grains (3 million [2–4]deaths and 82 million [59–109]DALYs), and low intake of fruits (2 million [1–4]deaths and 65 million [41–92]DALYs)were the leading dietary risk factors for deaths and DALYs globally and in many countries. Dietary data were from mixed sources and were not available for all countries, increasing the statistical uncertainty of our estimates. Interpretation: This study provides a comprehensive picture of the potential impact of suboptimal diet on NCD mortality and morbidity, highlighting the need for improving diet across nations. Our findings will inform implementation of evidence-based dietary interventions and provide a platform for evaluation of their impact on human health annually. Funding: Bill & Melinda Gates Foundation.
UR - http://www.scopus.com/inward/record.url?scp=85065230885&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(19)30041-8
DO - 10.1016/S0140-6736(19)30041-8
M3 - Article
C2 - 30954305
AN - SCOPUS:85065230885
SN - 0140-6736
VL - 393
SP - 1958
EP - 1972
JO - Lancet
JF - Lancet
IS - 10184
ER -